Approval · Notice of Compliance 28550 · 2022
HYZAAR: Notice of Compliance 28550
Issued July 7, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28550
- Date
- July 7, 2022
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph Conversion of Product Monograph to 2020 format Updates to package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYZAAR | Not yet assigned | — |
| HYZAAR DS | Not yet assigned | — |
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- LOSARTAN POTASSIUM 50 MG per TAB
- LOSARTAN POTASSIUM 100 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB